ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Adding Velcade Increased Overall Survival By 13.3 Months at Five-Year Analysis

December 30, 2011

DCCP Board Okays New, Recompeting Contracts Worth $4.6 Million In ‘81

October 17, 1980

Univ. Of Pittsburgh Plans Molecular Medicine Institute.

January 25, 2002

NCI to Fund Research Collaboration At HMOs, Health Care Provider Networks

July 11, 1997

April issue of Business & Regulatory Report included (8 additional pages).

April 30, 2004

In Brief: Sullivan Rejects Oregon Medicaid Rationing Plan; Howe To Head National Marrow Donor Program

August 7, 1992